Bio-Techne (TECH) Non-Current Debt (2014 - 2026)
Bio-Techne's (TECH) quarterly Non-Current Debt came in at $200.0 million in Q1 2026, down 39.39% year-on-year from $330.0 million in Q1 2025, and down 23.08% quarter-over-quarter from $260.0 million in Q4 2025.
Bio-Techne (TECH) Non-Current Debt (2014 - 2026) Analysis & Trends
Bio-Techne's Non-Current Debt history runs 13 years deep, the most recent figure standing at $200.0 million for Q1 2026.
- On a quarterly basis, Non-Current Debt fell 39.39% year-over-year to $200.0 million in Q1 2026; TTM through Mar 2026 was $200.0 million, a 39.39% decrease from a year earlier, with the FY2025 full-year figure at $346.0 million, up 8.46% from the prior year.
- Non-Current Debt slipped to $200.0 million in Q1 2026 per TECH's latest filing, from $260.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $447.0 million in Q4 2023 and bottomed at $200.0 million in Q4 2022.
- The 5-year median for Non-Current Debt is $300.0 million (2024), against an average of $312.1 million.
- Across the five-year window, Non-Current Debt jumped 123.5% in 2023 and sank 39.39% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $200.0 million in 2022, then surged by 123.5% to $447.0 million in 2023, then sank by 32.89% to $300.0 million in 2024, then fell by 13.33% to $260.0 million in 2025, then decreased by 23.08% to $200.0 million in 2026.
- Per Business Quant, the three latest TECH Non-Current Debt figures stand at $200.0 million (Q1 2026), $260.0 million (Q4 2025), and $300.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 200.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200.00 Mn |
| Dec 31, 2025 | 260.00 Mn |
| Sep 30, 2025 | 300.00 Mn |
| Jun 30, 2025 | 346.00 Mn |
| Mar 31, 2025 | 330.00 Mn |
| Dec 31, 2024 | 300.00 Mn |
| Sep 30, 2024 | 300.00 Mn |
| Jun 30, 2024 | 319.00 Mn |
| Mar 31, 2024 | 389.00 Mn |
| Dec 31, 2023 | 447.00 Mn |
| Sep 30, 2023 | 440.00 Mn |
| Jun 30, 2023 | 350.00 Mn |
| Mar 31, 2023 | 370.00 Mn |
| Dec 31, 2022 | 200.00 Mn |
| Sep 30, 2022 | 264.66 Mn |
| Jun 30, 2022 | 243.41 Mn |
| Mar 31, 2022 | 246.51 Mn |
| Dec 31, 2021 | 269.62 Mn |
| Sep 30, 2021 | 287.72 Mn |
| Jun 30, 2021 | 328.83 Mn |